The Global Single-use Bioprocessing Systems Market, by Product Type (Instruments and Accessories), by Application (Monoclonal Antibody Production, Vaccine Production, Patient Specific Cell Therapies, and Other Applications), by End User (Biotechnology and Pharmaceutical Companies, Research & Academic Research Institutes, and Contract Research Organizations(CRO) & Contract Manufacturing Organizations(CMO)) is estimated to bevalued at US$ 2.8 billion in 2018, and is projected to exhibit a CAGR of 17.2% over the forecast period (2018 - 2026).
The biopharmaceutical industry requires flexible manufacturing solutions to reduce long drug development timelines, reduce risk of cross contamination, and enables fast, user-friendly, and efficient processing of biologics. Single-use systems are widely adopted from common use storage bags for cell culture media and serum to certain application that have developed a major trend in biopharmaceutical manufacturing. Moreover, single-use or disposable bioprocessing trend is inclined toward commercial-scale manufacturing, owing to the continuous development by key players in the market.
Key players engaged in single-use bioprocessing systems market are launching technologically advanced products for the potential customers. For instance, in October 2014, Merck introduced PureFlex Plus Single-Use process container film. This new single-use process container film was designed for high-volume biopharmaceutical applications. Moreover, in June 2015, company launched Mobius 2000 liter single-use bioreactor. The new Mobius 2000 liter single-use bioreactor is configured with software, hardware, and single-use Flexware assemblies for suspension and adherent cell culture applications. In September 2017, Pall Corporation, a subsidiary of Danaher Corporation introduced Allegro single-use chromatography and Cadence continuous bioprocessing product portfolio. Both products enables scalable process integration for biopharmaceutical manufacturers. In September 2016, Sartorius AG introduced two Single-use Sartocon loop assemblies with integrated Polyethersulfone (PESU) membrane. The new single-use Sartocon self-contained filter loop assembly has been developed for use with company’s unique control unit, the FlexAct UD. In October 2014, Thermo Fisher Scientific introduced new HyPerforma Single-Use Fermenter at the BioProcess International Conference and Exhibition. The new HyPerforma Single-Use Fermenter was specifically designed for microbial fermentation and to scale up from the lab to GMP production.
Browse 22 Market Data Tables and 39 Figures spread through 160 Pages and in-depth TOC on "Single-use Bioprocessing Systems Market, by Product Type (Instruments and Accessories), by Application (Monoclonal Antibody Production, Vaccine Production, Patient Specific Cell Therapies and Other Applications), by End User (Biotechnology and Pharmaceutical Companies, Research & Academic Research Institutes, and Contract Research Organizations(CRO) & Contract Manufacturing Organizations(CMO)) - Global Forecast to 2026"
To know the latest trends and insights related to single-use bioprocessing systems market, click the link below:
Furthermore, strategic collaborations, agreement, and partnership among various key players in the market are driving the growth of single-use bioprocessing systems market. For instance, in April 2018, Pall Corporation made a strategic collaboration between its Biotech business unit and Artesyn Biosolutions. According to the collaboration, both the companies will deliver complete solutions from clinical to commercial-scale for single-use automated bioprocessing systems. In April 2017, Applikon Biotechnology partnered with Sanyo Trading Scientific Instruments. According to the partnership, Applikon and Sanyo will showcase Applikon products to potential customers in Japan. Moreover, in August 2016, General Electric Company made an exclusive agreement with Sealed Air Corporation. The agreement allows GE and Sealed Air to develop new primary film, which will be suitable for use in GE’s several single-use product portfolio. In June 2012, Applikon Biotechnology BV signed a bilateral supply agreement with Thermo Fisher Scientific Inc. According to the agreement, Thermo Fisher and Applikon have developed a single-use bioreactor.
Key takeaways of the single-use bioprocessing systems market: